UNICREDIT BANK/PUT/AMGEN/200/0.1/18.06.25 | Real-time BOERSE MUENCHEN 16:41:18 17/06/2024 BST | ||
| 0.43 EUR | 0.00% |
|
| Current month | -4.44% | ||
| 1 month | -6.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/06/24 | 0.43 | 0.00% |
| 14/06/24 | 0.43 | 0.00% |
| 13/06/24 | 0.43 | 0.00% |
| 12/06/24 | 0.43 | 0.00% |
| 11/06/24 | 0.43 | +2.38% |
Real-time BOERSE MUENCHEN
Last update June 17, 2024 at 04:41 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC7L5W |
| ISIN | DE000HC7L5W8 |
| Date issued | 22/06/2023 |
| Strike | 200 $ |
| Maturity | 18/06/2025 (366 Days) |
| Parity | 10 : 1 |
| Emission price | 1.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.87 € |
|---|---|
| Lowest since issue | 0.4 € |
| Spread | 0.03 € |
| Spread % | 6.82% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Warrants
- Warrant
